Interviews Archives - Page 4 of 4

Elliot Lander & Mark Berman Interview Part 1: A Window into Cell Surgical Network

November 22, 2013 February 1, 2021 / By Professor Paul Knoepfler, Ph.D. / 9 Comments

The Cell Surgical Network is a large and growing group of affiliated stem cell clinics across the US. The Network providers use stromal vascular fraction (SVF) interventions for a host of conditions on a for-profit basis. Drs. Elliot Lander and Mark Berman lead the Network. They agreed to do a Q&A interview with me. Below is Part 1, …

Elliot Lander & Mark Berman Interview Part 1: A Window into Cell Surgical Network Read More »

Joanne Kurtzberg interview, Part 2: clinics & stem cell field future

August 15, 2013 February 1, 2021 / By Professor Paul Knoepfler, Ph.D. / 7 Comments

I recently conducted an interview with Dr. Joanne Kurtzberg of Duke. You can see Part 1 of the interview here. Today in Part 2, I asked Dr. Kurtzberg some broader questions about the stem cell field. 1. How concerned are you about non-compliant stem cell interventions here in the US as well as stem cell …

Joanne Kurtzberg interview, Part 2: clinics & stem cell field future Read More »

Stem Cell Pioneer Joanne Kurtzberg interview, Part 1

August 6, 2013 February 1, 2021 / By Professor Paul Knoepfler, Ph.D. / 8 Comments

Dr. Joanne Kurtzberg is a stem cell pioneer and has advanced the development of innovative stem cell therapies including those based on umbilical cord blood. She is a faculty member at Duke where she conducts her clinical research. I recently interviewed Dr. Kurtzberg and below is Part 1 of 2 of the interview. Part 2, …

Stem Cell Pioneer Joanne Kurtzberg interview, Part 1 Read More »

Mike West Interview Part 3: key flaw in stem cell field

July 11, 2013 February 1, 2021 / By Professor Paul Knoepfler, Ph.D. / 7 Comments

Michael-West-PhD-CEO-of-BioTime-1-934x10241

I’m doing a series of posts on my recent conversation with BioTime CEO and pioneer of the stem cell field, Dr. Mike West. You can read Part 1 and Part 2 on Geron, ACT, and the history of the pluripotent stem cell field, particularly embryonic stem cells (ESCs). Today in Part 3, I am focusing on …

Mike West Interview Part 3: key flaw in stem cell field Read More »

Interview with BioTime CEO Michael West Part 1: a little stem cell history

June 26, 2013 February 1, 2021 / By Professor Paul Knoepfler, Ph.D. / 6 Comments

It was my pleasure recently to talk at length with Dr. Michael West, CEO of the Stem Cell Biotech, BioTime (BTX). West has been at the helm of BioTime since 2007 and is a true pioneer in the stem cell field. He founded Geron (GERN) and was a top leader at Advanced Cell Technology (ACT; stock …

Interview with BioTime CEO Michael West Part 1: a little stem cell history Read More »

Stemage Stem Cell Anti-Aging Cream 2.0: Interview with Dr. David Scharp

June 11, 2013 February 1, 2021 / By Professor Paul Knoepfler, Ph.D. / 5 Comments

Remember Stemage? They are the cosmetic company with Kathy Ireland as their spokesperson whose anti-aging cream includes extracts from human stem cells. In Part 1 of this blog series on Stemage I gave some key background and raised some important questions. I also sent some questions to the company and now more recently to the …

Stemage Stem Cell Anti-Aging Cream 2.0: Interview with Dr. David Scharp Read More »

Jeanne Loring interview: optimism on clinical translation of IPS cells

May 3, 2013 February 1, 2021 / By Professor Paul Knoepfler, Ph.D. / 3 Comments

One of my favorite stem cell scientists is Jeanne Loring of Scripps. She does great science and when you ask her questions, she frankly states her opinions and is clearly a gifted educator at heart too. Below is a Q&A interview I did with Jeanne on key issues of clinical translation of iPS cells. You …

Jeanne Loring interview: optimism on clinical translation of IPS cells Read More »

Interview with Arnold Caplan Part 2

March 18, 2013 February 1, 2021 / By Professor Paul Knoepfler, Ph.D. / 11 Comments

I recently interview Arnold Caplan, the father of the MSC field, and published part 1 of the interview (you can read it here). Today in part 2 we cover more topics of great importance related to MSCs including propagation, placebos, and patients as well as publishing. A hot topic in the stem cell world more …

Interview with Arnold Caplan Part 2 Read More »

Centeno and Sipp interview on FDA stem cell oversight

May 1, 2012 March 16, 2021 / By Professor Paul Knoepfler, Ph.D. / 34 Comments

I have interviewed two folks on the very important US vs. Regenerative Sciences legal case: Dr. Chris Centeno and Doug Sipp. More background on the case can be found at the FDA Law Blog. I thank them both for their time and for sharing their unique perspectives. I have specific rules for these interviews and …

Centeno and Sipp interview on FDA stem cell oversight Read More »

Anonymous stem cell scientist frankly answers questions about the field

September 2, 2010 February 1, 2021 / By Professor Paul Knoepfler, Ph.D.

Here an anonymous stem cell scientist frankly answers questions about the field in an interview with me. Of course I have to ask you about the recent U.S. court ruling essentially declaring all federal funding of human ES cell work illegal. What’s your take on this? ANSWER: The ruling has so many flaws in it. …

Anonymous stem cell scientist frankly answers questions about the field Read More »